Business
ARIUS to present at Chinese Global Financial Forum
ARIUS to present at Chinese Global Financial Forum.
About this update from Affinity Metals Corp
[{"type":"text","content":"\n\n\n\nTORONTO, Oct. 19 /CNW/ - ARIUS Research Inc., (TSX: ARI), a biotechnology\ncompany discovering and developing the next wave of antibody therapeutics,\ntoday announced that David Young, MD, President and Chief Executive Officer of\nARIUS, will speak at the Chinese Global Financial Forum. Dr. Young will\npresent on Saturday October 20th at 3:25 p.m. and will be available prior to\nand following his presentation at booth No.706. The conference is being held\nat the Hilton Suites Toronto/Markham Conference Centre & Spa. Dr. Young will\nprovide an overview of ARIUS' business and will update the audience on\nmilestones for the Company's lad programs in cancer.\n\n\nAbout ARIUS\n\n\nARIUS is a biotechnology company discovering and developing the next wave\nof antibody therapeutics. Established in 1999, ARIUS has built a proprietary\ntechnology platform, FunctionFIRST(TM), that rapidly identifies and selects\nantibodies based on their functional ability to affect disease. This antibody\ngeneration engine has enabled ARIUS to assemble a portfolio of more than 400\nantibody candidates. In addition to the antibodies it is developing in-house,\nARIUS has ongoing partnerships with key biotechnology and drug development\ncompanies. ARIUS is listed on the TSX under the symbol "ARI". For further\ninformation, visit www.ariusresearch.com\n\n\nForward-Looking Statements\n\n\nCertain statements in this news release constitute "forward-looking \nstatements" within the meaning of the Private Securities Litigation Reform Act\nof 1995, which involve known and unknown risks, uncertainties and other\nfactors that may cause our actual results to be materially different from any\nfuture results, performance or achievements expressed or implied by such\nstatements. Forward-looking statements in this release include, but are not\nlimited to, ARIUS successfully advancing its new product programs as well as\nlicensing opportunities. These statements are only predictions and actual\nevents or results may differ materially. Factors that could cause such actual\nevents or results expressed or implied by such forward-looking statements to\ndiffer materially from any future results expressed or implied by such\nstatements include, but are not limited to: early stage of development;\ntechnology and product development; dependence on ...